Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02898233 · ClinicalTrials.gov registry record · NA
Augmenting Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder With Low-Level Light Therapy
A NA study, sponsored by University of Texas at Austin.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02898233 is a NA study that was terminated before completion, run by University of Texas at Austin. The registered enrollment target is 20 participants.
The verdict
NCT02898233, a NA study, was terminated before completion, sponsored by University of Texas at Austin.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand how low-level light therapy (LLLT) can be used to augment the antidepressant effects of Deprexis, an internet-based treatment program for depression, for participants with current major depressive disorder. The researchers will administer active and placebo LLLT to the right forehead of participants who show an improvement of at least 10% in depressive symptoms from baseline after two weeks of Deprexis treatment. Hypothesis: Participants who receive active LLLT will show a greater reduction of depressive symptoms than participants who receive placebo LLLT.
Interventions
- OTHER Deprexis
- DEVICE Active low-level light therapy
- DEVICE Sham low-level light therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-02 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02898233
The ClinicalTrials.gov registry entry for NCT02898233 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Deprexis is the first listed.
NCT02898233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02898233 about?
NCT02898233 is a clinical study titled "Augmenting Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder With Low-Level Light Therapy". The purpose of this study is to better understand how low-level light therapy (LLLT) can be used to augment the antidepressant effects of Deprexis, an internet-based treatment program for depression, for participants with current major depressive disorder. The researchers will administer active and ...
What is the current status of trial NCT02898233?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2016-02. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT02898233?
The interventions under investigation include: Deprexis (OTHER), Active low-level light therapy (DEVICE), Sham low-level light therapy (DEVICE).
Who is sponsoring clinical trial NCT02898233?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.